Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia: A Systematic Review.
Conclusion: Available evidence about the risk-benefit ratio of antiplatelet therapy in adults with ET is highly uncertain.
Primary Funding Source: Regional Medical Associates. (PROSPERO: CRD42015027051).
PMID: 28632284 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Chu DK, Hillis CM, Leong DP, Anand SS, Siegal DM Tags: Ann Intern Med Source Type: research